BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26048640)

  • 1. Discrepancies in addressing overdose prevention through prescription monitoring programs.
    Green TC; Bowman S; Davis C; Los C; McHugh K; Friedmann PD
    Drug Alcohol Depend; 2015 Aug; 153():355-8. PubMed ID: 26048640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws.
    Davis CS; Johnston JE; Pierce MW
    Am J Public Health; 2015 Nov; 105(11):e9-e11. PubMed ID: 26378849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
    Pardo B
    Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the overdose epidemic requires timely access to data to guide interventions.
    Davis CS; Green TC; Zaller ND
    Drug Alcohol Rev; 2016 Jul; 35(4):383-6. PubMed ID: 26382016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.
    Siegler A; Tuazon E; Bradley O'Brien D; Paone D
    Int J Drug Policy; 2014 May; 25(3):569-74. PubMed ID: 24412006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard.
    Waye KM; Yedinak JL; Koziol J; Marshall BDL
    Int J Drug Policy; 2018 Dec; 62():86-93. PubMed ID: 30384027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic patterns of prescription opioids and opioid overdose deaths in New York State, 2013-2015.
    Romeiser JL; Labriola J; Meliker JR
    Drug Alcohol Depend; 2019 Feb; 195():94-100. PubMed ID: 30605866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good Samaritan harm reduction policy and drug overdose deaths.
    Atkins DN; Durrance CP; Kim Y
    Health Serv Res; 2019 Apr; 54(2):407-416. PubMed ID: 30740691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):e29-49. PubMed ID: 26451760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):2373. PubMed ID: 26451757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a health communication campaign to promote the Texas prescription monitoring program.
    Mackert M; Pounders K; Brown LE; Kirtz S; Wagner JH; Ring D; Hill L; Wilcox G; Murthy D; Tierney W; Innerarity S; McGlone M; Holleran Steiker LK; DeSalvo K; Bernhardt JM; Pretorius K
    Health Mark Q; 2020; 37(3):222-231. PubMed ID: 32790502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Controlled Substance Receipt Patterns to Predict Prescription Overdose Death.
    Holt CT; McCall KL; Cattabriga G; Tu C; Smalley EK; Nichols SD
    Pharmacology; 2018; 101(3-4):140-147. PubMed ID: 29248915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-level strategies for reducing prescription drug overdose deaths: Utah's prescription safety program.
    Johnson EM; Porucznik CA; Anderson JW; Rolfs RT
    Pain Med; 2011 Jun; 12 Suppl 2():S66-72. PubMed ID: 21668759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators.
    Katz N; Houle B; Fernandez KC; Kreiner P; Thomas CP; Kim M; Carrow GM; Audet A; Brushwood D
    Pain Med; 2008; 9(5):587-94. PubMed ID: 18565002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing prescription opioid overdose: data support a comprehensive policy approach.
    Jones CM; Lurie P; Woodcock J
    JAMA; 2014 Nov; 312(17):1733-4. PubMed ID: 25275855
    [No Abstract]   [Full Text] [Related]  

  • 16. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
    Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
    JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.
    Mattson CL; O'Donnell J; Kariisa M; Seth P; Scholl L; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):945-951. PubMed ID: 30161105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will You Save Me? Injury Prevention Strategies to Prevent Opioid Overdose.
    Valdez AM
    J Emerg Nurs; 2019 Jan; 45(1):90-93. PubMed ID: 30616770
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient Characteristics and Outcomes in Unintentional, Non-fatal Prescription Opioid Overdoses: A Systematic Review.
    Elzey MJ; Barden SM; Edwards ES
    Pain Physician; 2016 May; 19(4):215-28. PubMed ID: 27228510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.